nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—S100B—urinary bladder cancer	0.569	1	CbGaD
Pentamidine—CYP4A11—Cisplatin—urinary bladder cancer	0.119	0.562	CbGbCtD
Pentamidine—CYP3A4—Thiotepa—urinary bladder cancer	0.0184	0.0868	CbGbCtD
Pentamidine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0148	0.0695	CbGbCtD
Pentamidine—CYP3A5—Etoposide—urinary bladder cancer	0.0128	0.0604	CbGbCtD
Pentamidine—CYP2C8—Etoposide—urinary bladder cancer	0.0123	0.058	CbGbCtD
Pentamidine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0114	0.0538	CbGbCtD
Pentamidine—CYP1A2—Etoposide—urinary bladder cancer	0.00954	0.0449	CbGbCtD
Pentamidine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00536	0.0252	CbGbCtD
Pentamidine—CYP3A4—Etoposide—urinary bladder cancer	0.005	0.0235	CbGbCtD
Pentamidine—TRDMT1—female reproductive system—urinary bladder cancer	0.00435	0.12	CbGeAlD
Pentamidine—AOC1—prostate gland—urinary bladder cancer	0.00359	0.0989	CbGeAlD
Pentamidine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00341	0.0161	CbGbCtD
Pentamidine—AOC1—renal system—urinary bladder cancer	0.00245	0.0674	CbGeAlD
Pentamidine—AOC1—urethra—urinary bladder cancer	0.00241	0.0662	CbGeAlD
Pentamidine—CYP2C19—urine—urinary bladder cancer	0.00234	0.0645	CbGeAlD
Pentamidine—CYP4A11—renal system—urinary bladder cancer	0.00203	0.056	CbGeAlD
Pentamidine—AOC1—female reproductive system—urinary bladder cancer	0.00196	0.054	CbGeAlD
Pentamidine—CYP1A2—urine—urinary bladder cancer	0.00191	0.0526	CbGeAlD
Pentamidine—AOC1—vagina—urinary bladder cancer	0.00177	0.0488	CbGeAlD
Pentamidine—Ospemifene—ESR1—urinary bladder cancer	0.00154	1	CrCbGaD
Pentamidine—CYP4A11—vagina—urinary bladder cancer	0.00147	0.0406	CbGeAlD
Pentamidine—CYP3A4—urine—urinary bladder cancer	0.00138	0.0381	CbGeAlD
Pentamidine—CYP2D6—urine—urinary bladder cancer	0.00136	0.0375	CbGeAlD
Pentamidine—AOC1—lymph node—urinary bladder cancer	0.00115	0.0316	CbGeAlD
Pentamidine—S100B—lymph node—urinary bladder cancer	0.001	0.0275	CbGeAlD
Pentamidine—CYP3A5—prostate gland—urinary bladder cancer	0.000662	0.0182	CbGeAlD
Pentamidine—CYP2C8—renal system—urinary bladder cancer	0.0005	0.0138	CbGeAlD
Pentamidine—CYP1A1—epithelium—urinary bladder cancer	0.000498	0.0137	CbGeAlD
Pentamidine—CYP1A2—renal system—urinary bladder cancer	0.000468	0.0129	CbGeAlD
Pentamidine—CYP1A1—renal system—urinary bladder cancer	0.000461	0.0127	CbGeAlD
Pentamidine—CYP1A1—urethra—urinary bladder cancer	0.000453	0.0125	CbGeAlD
Pentamidine—CYP3A5—renal system—urinary bladder cancer	0.000451	0.0124	CbGeAlD
Pentamidine—CYP2C19—vagina—urinary bladder cancer	0.000415	0.0114	CbGeAlD
Pentamidine—CYP2C8—female reproductive system—urinary bladder cancer	0.0004	0.011	CbGeAlD
Pentamidine—CYP1A1—female reproductive system—urinary bladder cancer	0.00037	0.0102	CbGeAlD
Pentamidine—CYP2C8—vagina—urinary bladder cancer	0.000362	0.00997	CbGeAlD
Pentamidine—CYP3A4—renal system—urinary bladder cancer	0.000339	0.00932	CbGeAlD
Pentamidine—CYP1A1—vagina—urinary bladder cancer	0.000334	0.0092	CbGeAlD
Pentamidine—CYP2D6—renal system—urinary bladder cancer	0.000333	0.00917	CbGeAlD
Pentamidine—CYP3A5—vagina—urinary bladder cancer	0.000327	0.009	CbGeAlD
Pentamidine—CYP3A4—female reproductive system—urinary bladder cancer	0.000271	0.00747	CbGeAlD
Pentamidine—CYP2D6—female reproductive system—urinary bladder cancer	0.000267	0.00735	CbGeAlD
Pentamidine—CYP1A1—lymph node—urinary bladder cancer	0.000216	0.00595	CbGeAlD
Pentamidine—Body temperature increased—Fluorouracil—urinary bladder cancer	7.93e-05	0.000688	CcSEcCtD
Pentamidine—Eosinophilia—Doxorubicin—urinary bladder cancer	7.87e-05	0.000682	CcSEcCtD
Pentamidine—Feeling abnormal—Cisplatin—urinary bladder cancer	7.84e-05	0.00068	CcSEcCtD
Pentamidine—Paraesthesia—Etoposide—urinary bladder cancer	7.82e-05	0.000678	CcSEcCtD
Pentamidine—Haematuria—Methotrexate—urinary bladder cancer	7.8e-05	0.000676	CcSEcCtD
Pentamidine—Pancreatitis—Doxorubicin—urinary bladder cancer	7.79e-05	0.000676	CcSEcCtD
Pentamidine—Dyspnoea—Etoposide—urinary bladder cancer	7.77e-05	0.000674	CcSEcCtD
Pentamidine—Hyperglycaemia—Epirubicin—urinary bladder cancer	7.75e-05	0.000672	CcSEcCtD
Pentamidine—Somnolence—Etoposide—urinary bladder cancer	7.75e-05	0.000672	CcSEcCtD
Pentamidine—Vomiting—Thiotepa—urinary bladder cancer	7.71e-05	0.000669	CcSEcCtD
Pentamidine—Drowsiness—Epirubicin—urinary bladder cancer	7.66e-05	0.000664	CcSEcCtD
Pentamidine—Rash—Thiotepa—urinary bladder cancer	7.65e-05	0.000663	CcSEcCtD
Pentamidine—Bronchitis—Doxorubicin—urinary bladder cancer	7.64e-05	0.000663	CcSEcCtD
Pentamidine—Dermatitis—Thiotepa—urinary bladder cancer	7.64e-05	0.000663	CcSEcCtD
Pentamidine—Headache—Thiotepa—urinary bladder cancer	7.6e-05	0.000659	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	7.59e-05	0.000658	CcSEcCtD
Pentamidine—Decreased appetite—Etoposide—urinary bladder cancer	7.57e-05	0.000657	CcSEcCtD
Pentamidine—Pancytopenia—Doxorubicin—urinary bladder cancer	7.55e-05	0.000654	CcSEcCtD
Pentamidine—Renal failure—Epirubicin—urinary bladder cancer	7.53e-05	0.000653	CcSEcCtD
Pentamidine—Body temperature increased—Cisplatin—urinary bladder cancer	7.52e-05	0.000652	CcSEcCtD
Pentamidine—Fatigue—Etoposide—urinary bladder cancer	7.51e-05	0.000651	CcSEcCtD
Pentamidine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	7.51e-05	0.000651	CcSEcCtD
Pentamidine—Stomatitis—Epirubicin—urinary bladder cancer	7.46e-05	0.000647	CcSEcCtD
Pentamidine—Constipation—Etoposide—urinary bladder cancer	7.45e-05	0.000646	CcSEcCtD
Pentamidine—Pain—Etoposide—urinary bladder cancer	7.45e-05	0.000646	CcSEcCtD
Pentamidine—Conjunctivitis—Epirubicin—urinary bladder cancer	7.44e-05	0.000645	CcSEcCtD
Pentamidine—Neutropenia—Doxorubicin—urinary bladder cancer	7.43e-05	0.000644	CcSEcCtD
Pentamidine—Hypersensitivity—Fluorouracil—urinary bladder cancer	7.39e-05	0.000641	CcSEcCtD
Pentamidine—Hepatitis—Methotrexate—urinary bladder cancer	7.35e-05	0.000637	CcSEcCtD
Pentamidine—Asthenia—Gemcitabine—urinary bladder cancer	7.32e-05	0.000635	CcSEcCtD
Pentamidine—Haematuria—Epirubicin—urinary bladder cancer	7.3e-05	0.000633	CcSEcCtD
Pentamidine—Pharyngitis—Methotrexate—urinary bladder cancer	7.29e-05	0.000632	CcSEcCtD
Pentamidine—Pruritus—Gemcitabine—urinary bladder cancer	7.22e-05	0.000626	CcSEcCtD
Pentamidine—Nausea—Thiotepa—urinary bladder cancer	7.21e-05	0.000625	CcSEcCtD
Pentamidine—Sinusitis—Epirubicin—urinary bladder cancer	7.18e-05	0.000623	CcSEcCtD
Pentamidine—Feeling abnormal—Etoposide—urinary bladder cancer	7.18e-05	0.000623	CcSEcCtD
Pentamidine—Hyperglycaemia—Doxorubicin—urinary bladder cancer	7.17e-05	0.000622	CcSEcCtD
Pentamidine—Gastrointestinal pain—Etoposide—urinary bladder cancer	7.13e-05	0.000618	CcSEcCtD
Pentamidine—Pruritus—Fluorouracil—urinary bladder cancer	7.1e-05	0.000615	CcSEcCtD
Pentamidine—Drowsiness—Doxorubicin—urinary bladder cancer	7.09e-05	0.000614	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	7.03e-05	0.000609	CcSEcCtD
Pentamidine—Hypersensitivity—Cisplatin—urinary bladder cancer	7.01e-05	0.000608	CcSEcCtD
Pentamidine—Bradycardia—Epirubicin—urinary bladder cancer	7e-05	0.000607	CcSEcCtD
Pentamidine—Diarrhoea—Gemcitabine—urinary bladder cancer	6.98e-05	0.000605	CcSEcCtD
Pentamidine—Renal failure—Doxorubicin—urinary bladder cancer	6.97e-05	0.000604	CcSEcCtD
Pentamidine—Erythema multiforme—Methotrexate—urinary bladder cancer	6.95e-05	0.000602	CcSEcCtD
Pentamidine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	6.95e-05	0.000602	CcSEcCtD
Pentamidine—Urticaria—Etoposide—urinary bladder cancer	6.92e-05	0.0006	CcSEcCtD
Pentamidine—Stomatitis—Doxorubicin—urinary bladder cancer	6.91e-05	0.000599	CcSEcCtD
Pentamidine—Rhinitis—Epirubicin—urinary bladder cancer	6.89e-05	0.000598	CcSEcCtD
Pentamidine—Body temperature increased—Etoposide—urinary bladder cancer	6.89e-05	0.000597	CcSEcCtD
Pentamidine—Abdominal pain—Etoposide—urinary bladder cancer	6.89e-05	0.000597	CcSEcCtD
Pentamidine—Conjunctivitis—Doxorubicin—urinary bladder cancer	6.89e-05	0.000597	CcSEcCtD
Pentamidine—Hepatitis—Epirubicin—urinary bladder cancer	6.87e-05	0.000596	CcSEcCtD
Pentamidine—Diarrhoea—Fluorouracil—urinary bladder cancer	6.86e-05	0.000595	CcSEcCtD
Pentamidine—Hypoaesthesia—Epirubicin—urinary bladder cancer	6.84e-05	0.000593	CcSEcCtD
Pentamidine—Asthenia—Cisplatin—urinary bladder cancer	6.82e-05	0.000592	CcSEcCtD
Pentamidine—Pharyngitis—Epirubicin—urinary bladder cancer	6.82e-05	0.000592	CcSEcCtD
Pentamidine—Oedema peripheral—Epirubicin—urinary bladder cancer	6.77e-05	0.000587	CcSEcCtD
Pentamidine—Haematuria—Doxorubicin—urinary bladder cancer	6.76e-05	0.000586	CcSEcCtD
Pentamidine—Sinusitis—Doxorubicin—urinary bladder cancer	6.65e-05	0.000576	CcSEcCtD
Pentamidine—Dizziness—Fluorouracil—urinary bladder cancer	6.63e-05	0.000575	CcSEcCtD
Pentamidine—Chills—Methotrexate—urinary bladder cancer	6.59e-05	0.000571	CcSEcCtD
Pentamidine—Diarrhoea—Cisplatin—urinary bladder cancer	6.51e-05	0.000564	CcSEcCtD
Pentamidine—Erythema multiforme—Epirubicin—urinary bladder cancer	6.5e-05	0.000564	CcSEcCtD
Pentamidine—Vomiting—Gemcitabine—urinary bladder cancer	6.49e-05	0.000563	CcSEcCtD
Pentamidine—Bradycardia—Doxorubicin—urinary bladder cancer	6.48e-05	0.000561	CcSEcCtD
Pentamidine—Rash—Gemcitabine—urinary bladder cancer	6.43e-05	0.000558	CcSEcCtD
Pentamidine—Dermatitis—Gemcitabine—urinary bladder cancer	6.43e-05	0.000557	CcSEcCtD
Pentamidine—Hypersensitivity—Etoposide—urinary bladder cancer	6.42e-05	0.000557	CcSEcCtD
Pentamidine—Erythema—Methotrexate—urinary bladder cancer	6.39e-05	0.000554	CcSEcCtD
Pentamidine—Headache—Gemcitabine—urinary bladder cancer	6.39e-05	0.000554	CcSEcCtD
Pentamidine—Flushing—Epirubicin—urinary bladder cancer	6.38e-05	0.000553	CcSEcCtD
Pentamidine—Vomiting—Fluorouracil—urinary bladder cancer	6.38e-05	0.000553	CcSEcCtD
Pentamidine—Rhinitis—Doxorubicin—urinary bladder cancer	6.38e-05	0.000553	CcSEcCtD
Pentamidine—Hepatitis—Doxorubicin—urinary bladder cancer	6.36e-05	0.000552	CcSEcCtD
Pentamidine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	6.33e-05	0.000549	CcSEcCtD
Pentamidine—Rash—Fluorouracil—urinary bladder cancer	6.33e-05	0.000548	CcSEcCtD
Pentamidine—Dermatitis—Fluorouracil—urinary bladder cancer	6.32e-05	0.000548	CcSEcCtD
Pentamidine—Pharyngitis—Doxorubicin—urinary bladder cancer	6.31e-05	0.000547	CcSEcCtD
Pentamidine—Headache—Fluorouracil—urinary bladder cancer	6.29e-05	0.000545	CcSEcCtD
Pentamidine—Oedema peripheral—Doxorubicin—urinary bladder cancer	6.27e-05	0.000543	CcSEcCtD
Pentamidine—Dysgeusia—Methotrexate—urinary bladder cancer	6.26e-05	0.000543	CcSEcCtD
Pentamidine—Asthenia—Etoposide—urinary bladder cancer	6.25e-05	0.000542	CcSEcCtD
Pentamidine—Chills—Epirubicin—urinary bladder cancer	6.17e-05	0.000535	CcSEcCtD
Pentamidine—Pruritus—Etoposide—urinary bladder cancer	6.16e-05	0.000534	CcSEcCtD
Pentamidine—Arrhythmia—Epirubicin—urinary bladder cancer	6.14e-05	0.000532	CcSEcCtD
Pentamidine—Nausea—Gemcitabine—urinary bladder cancer	6.06e-05	0.000526	CcSEcCtD
Pentamidine—Vomiting—Cisplatin—urinary bladder cancer	6.05e-05	0.000524	CcSEcCtD
Pentamidine—Vision blurred—Methotrexate—urinary bladder cancer	6.03e-05	0.000523	CcSEcCtD
Pentamidine—Erythema multiforme—Doxorubicin—urinary bladder cancer	6.01e-05	0.000521	CcSEcCtD
Pentamidine—Rash—Cisplatin—urinary bladder cancer	6e-05	0.00052	CcSEcCtD
Pentamidine—Dermatitis—Cisplatin—urinary bladder cancer	5.99e-05	0.000519	CcSEcCtD
Pentamidine—Erythema—Epirubicin—urinary bladder cancer	5.98e-05	0.000519	CcSEcCtD
Pentamidine—Diarrhoea—Etoposide—urinary bladder cancer	5.96e-05	0.000517	CcSEcCtD
Pentamidine—Nausea—Fluorouracil—urinary bladder cancer	5.96e-05	0.000517	CcSEcCtD
Pentamidine—Anaemia—Methotrexate—urinary bladder cancer	5.91e-05	0.000512	CcSEcCtD
Pentamidine—Flushing—Doxorubicin—urinary bladder cancer	5.9e-05	0.000512	CcSEcCtD
Pentamidine—Tension—Epirubicin—urinary bladder cancer	5.87e-05	0.000509	CcSEcCtD
Pentamidine—Dysgeusia—Epirubicin—urinary bladder cancer	5.86e-05	0.000508	CcSEcCtD
Pentamidine—Nervousness—Epirubicin—urinary bladder cancer	5.81e-05	0.000504	CcSEcCtD
Pentamidine—Dizziness—Etoposide—urinary bladder cancer	5.76e-05	0.0005	CcSEcCtD
Pentamidine—Vertigo—Methotrexate—urinary bladder cancer	5.75e-05	0.000498	CcSEcCtD
Pentamidine—Leukopenia—Methotrexate—urinary bladder cancer	5.72e-05	0.000496	CcSEcCtD
Pentamidine—Chills—Doxorubicin—urinary bladder cancer	5.71e-05	0.000495	CcSEcCtD
Pentamidine—Arrhythmia—Doxorubicin—urinary bladder cancer	5.68e-05	0.000493	CcSEcCtD
Pentamidine—Nausea—Cisplatin—urinary bladder cancer	5.65e-05	0.00049	CcSEcCtD
Pentamidine—Vision blurred—Epirubicin—urinary bladder cancer	5.64e-05	0.000489	CcSEcCtD
Pentamidine—Cough—Methotrexate—urinary bladder cancer	5.58e-05	0.000484	CcSEcCtD
Pentamidine—Convulsion—Methotrexate—urinary bladder cancer	5.54e-05	0.00048	CcSEcCtD
Pentamidine—Vomiting—Etoposide—urinary bladder cancer	5.54e-05	0.00048	CcSEcCtD
Pentamidine—Erythema—Doxorubicin—urinary bladder cancer	5.54e-05	0.00048	CcSEcCtD
Pentamidine—Anaemia—Epirubicin—urinary bladder cancer	5.53e-05	0.00048	CcSEcCtD
Pentamidine—Rash—Etoposide—urinary bladder cancer	5.49e-05	0.000476	CcSEcCtD
Pentamidine—Dermatitis—Etoposide—urinary bladder cancer	5.49e-05	0.000476	CcSEcCtD
Pentamidine—Headache—Etoposide—urinary bladder cancer	5.46e-05	0.000473	CcSEcCtD
Pentamidine—Myalgia—Methotrexate—urinary bladder cancer	5.44e-05	0.000472	CcSEcCtD
Pentamidine—Arthralgia—Methotrexate—urinary bladder cancer	5.44e-05	0.000472	CcSEcCtD
Pentamidine—Chest pain—Methotrexate—urinary bladder cancer	5.44e-05	0.000472	CcSEcCtD
Pentamidine—Tension—Doxorubicin—urinary bladder cancer	5.43e-05	0.000471	CcSEcCtD
Pentamidine—Dysgeusia—Doxorubicin—urinary bladder cancer	5.42e-05	0.00047	CcSEcCtD
Pentamidine—Discomfort—Methotrexate—urinary bladder cancer	5.38e-05	0.000466	CcSEcCtD
Pentamidine—Nervousness—Doxorubicin—urinary bladder cancer	5.38e-05	0.000466	CcSEcCtD
Pentamidine—Vertigo—Epirubicin—urinary bladder cancer	5.38e-05	0.000466	CcSEcCtD
Pentamidine—Syncope—Epirubicin—urinary bladder cancer	5.37e-05	0.000465	CcSEcCtD
Pentamidine—Leukopenia—Epirubicin—urinary bladder cancer	5.36e-05	0.000464	CcSEcCtD
Pentamidine—Palpitations—Epirubicin—urinary bladder cancer	5.29e-05	0.000459	CcSEcCtD
Pentamidine—Confusional state—Methotrexate—urinary bladder cancer	5.26e-05	0.000456	CcSEcCtD
Pentamidine—Loss of consciousness—Epirubicin—urinary bladder cancer	5.26e-05	0.000456	CcSEcCtD
Pentamidine—Cough—Epirubicin—urinary bladder cancer	5.22e-05	0.000453	CcSEcCtD
Pentamidine—Anaphylactic shock—Methotrexate—urinary bladder cancer	5.22e-05	0.000453	CcSEcCtD
Pentamidine—Vision blurred—Doxorubicin—urinary bladder cancer	5.22e-05	0.000452	CcSEcCtD
Pentamidine—Convulsion—Epirubicin—urinary bladder cancer	5.19e-05	0.00045	CcSEcCtD
Pentamidine—Infection—Methotrexate—urinary bladder cancer	5.19e-05	0.00045	CcSEcCtD
Pentamidine—Nausea—Etoposide—urinary bladder cancer	5.18e-05	0.000449	CcSEcCtD
Pentamidine—Hypertension—Epirubicin—urinary bladder cancer	5.17e-05	0.000448	CcSEcCtD
Pentamidine—Anaemia—Doxorubicin—urinary bladder cancer	5.12e-05	0.000444	CcSEcCtD
Pentamidine—Thrombocytopenia—Methotrexate—urinary bladder cancer	5.11e-05	0.000443	CcSEcCtD
Pentamidine—Arthralgia—Epirubicin—urinary bladder cancer	5.1e-05	0.000442	CcSEcCtD
Pentamidine—Myalgia—Epirubicin—urinary bladder cancer	5.1e-05	0.000442	CcSEcCtD
Pentamidine—Chest pain—Epirubicin—urinary bladder cancer	5.1e-05	0.000442	CcSEcCtD
Pentamidine—Anxiety—Epirubicin—urinary bladder cancer	5.08e-05	0.00044	CcSEcCtD
Pentamidine—Discomfort—Epirubicin—urinary bladder cancer	5.03e-05	0.000436	CcSEcCtD
Pentamidine—Dry mouth—Epirubicin—urinary bladder cancer	4.98e-05	0.000432	CcSEcCtD
Pentamidine—Vertigo—Doxorubicin—urinary bladder cancer	4.98e-05	0.000431	CcSEcCtD
Pentamidine—Anorexia—Methotrexate—urinary bladder cancer	4.97e-05	0.000431	CcSEcCtD
Pentamidine—Syncope—Doxorubicin—urinary bladder cancer	4.97e-05	0.000431	CcSEcCtD
Pentamidine—Leukopenia—Doxorubicin—urinary bladder cancer	4.96e-05	0.00043	CcSEcCtD
Pentamidine—Confusional state—Epirubicin—urinary bladder cancer	4.92e-05	0.000427	CcSEcCtD
Pentamidine—Palpitations—Doxorubicin—urinary bladder cancer	4.89e-05	0.000424	CcSEcCtD
Pentamidine—Anaphylactic shock—Epirubicin—urinary bladder cancer	4.88e-05	0.000423	CcSEcCtD
Pentamidine—Hypotension—Methotrexate—urinary bladder cancer	4.88e-05	0.000423	CcSEcCtD
Pentamidine—Loss of consciousness—Doxorubicin—urinary bladder cancer	4.87e-05	0.000422	CcSEcCtD
Pentamidine—Infection—Epirubicin—urinary bladder cancer	4.85e-05	0.000421	CcSEcCtD
Pentamidine—Cough—Doxorubicin—urinary bladder cancer	4.83e-05	0.000419	CcSEcCtD
Pentamidine—Shock—Epirubicin—urinary bladder cancer	4.81e-05	0.000417	CcSEcCtD
Pentamidine—Convulsion—Doxorubicin—urinary bladder cancer	4.8e-05	0.000416	CcSEcCtD
Pentamidine—Thrombocytopenia—Epirubicin—urinary bladder cancer	4.78e-05	0.000415	CcSEcCtD
Pentamidine—Hypertension—Doxorubicin—urinary bladder cancer	4.78e-05	0.000415	CcSEcCtD
Pentamidine—Tachycardia—Epirubicin—urinary bladder cancer	4.77e-05	0.000413	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	4.76e-05	0.000412	CcSEcCtD
Pentamidine—Insomnia—Methotrexate—urinary bladder cancer	4.72e-05	0.000409	CcSEcCtD
Pentamidine—Chest pain—Doxorubicin—urinary bladder cancer	4.71e-05	0.000409	CcSEcCtD
Pentamidine—Myalgia—Doxorubicin—urinary bladder cancer	4.71e-05	0.000409	CcSEcCtD
Pentamidine—Arthralgia—Doxorubicin—urinary bladder cancer	4.71e-05	0.000409	CcSEcCtD
Pentamidine—Anxiety—Doxorubicin—urinary bladder cancer	4.7e-05	0.000407	CcSEcCtD
Pentamidine—Paraesthesia—Methotrexate—urinary bladder cancer	4.69e-05	0.000406	CcSEcCtD
Pentamidine—Discomfort—Doxorubicin—urinary bladder cancer	4.66e-05	0.000404	CcSEcCtD
Pentamidine—Anorexia—Epirubicin—urinary bladder cancer	4.66e-05	0.000404	CcSEcCtD
Pentamidine—Dyspnoea—Methotrexate—urinary bladder cancer	4.65e-05	0.000403	CcSEcCtD
Pentamidine—Somnolence—Methotrexate—urinary bladder cancer	4.64e-05	0.000402	CcSEcCtD
Pentamidine—Dry mouth—Doxorubicin—urinary bladder cancer	4.61e-05	0.0004	CcSEcCtD
Pentamidine—Dyspepsia—Methotrexate—urinary bladder cancer	4.59e-05	0.000398	CcSEcCtD
Pentamidine—Hypotension—Epirubicin—urinary bladder cancer	4.56e-05	0.000396	CcSEcCtD
Pentamidine—Confusional state—Doxorubicin—urinary bladder cancer	4.56e-05	0.000395	CcSEcCtD
Pentamidine—Decreased appetite—Methotrexate—urinary bladder cancer	4.54e-05	0.000393	CcSEcCtD
Pentamidine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	4.52e-05	0.000392	CcSEcCtD
Pentamidine—Fatigue—Methotrexate—urinary bladder cancer	4.5e-05	0.00039	CcSEcCtD
Pentamidine—Infection—Doxorubicin—urinary bladder cancer	4.49e-05	0.000389	CcSEcCtD
Pentamidine—Pain—Methotrexate—urinary bladder cancer	4.46e-05	0.000387	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	4.45e-05	0.000386	CcSEcCtD
Pentamidine—Shock—Doxorubicin—urinary bladder cancer	4.45e-05	0.000386	CcSEcCtD
Pentamidine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	4.42e-05	0.000384	CcSEcCtD
Pentamidine—Insomnia—Epirubicin—urinary bladder cancer	4.42e-05	0.000383	CcSEcCtD
Pentamidine—Tachycardia—Doxorubicin—urinary bladder cancer	4.41e-05	0.000382	CcSEcCtD
Pentamidine—Paraesthesia—Epirubicin—urinary bladder cancer	4.39e-05	0.00038	CcSEcCtD
Pentamidine—Dyspnoea—Epirubicin—urinary bladder cancer	4.35e-05	0.000378	CcSEcCtD
Pentamidine—Somnolence—Epirubicin—urinary bladder cancer	4.34e-05	0.000376	CcSEcCtD
Pentamidine—Anorexia—Doxorubicin—urinary bladder cancer	4.31e-05	0.000374	CcSEcCtD
Pentamidine—Feeling abnormal—Methotrexate—urinary bladder cancer	4.3e-05	0.000373	CcSEcCtD
Pentamidine—Dyspepsia—Epirubicin—urinary bladder cancer	4.3e-05	0.000373	CcSEcCtD
Pentamidine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	4.27e-05	0.00037	CcSEcCtD
Pentamidine—Decreased appetite—Epirubicin—urinary bladder cancer	4.25e-05	0.000368	CcSEcCtD
Pentamidine—Hypotension—Doxorubicin—urinary bladder cancer	4.22e-05	0.000366	CcSEcCtD
Pentamidine—Fatigue—Epirubicin—urinary bladder cancer	4.21e-05	0.000365	CcSEcCtD
Pentamidine—Pain—Epirubicin—urinary bladder cancer	4.18e-05	0.000362	CcSEcCtD
Pentamidine—Constipation—Epirubicin—urinary bladder cancer	4.18e-05	0.000362	CcSEcCtD
Pentamidine—Urticaria—Methotrexate—urinary bladder cancer	4.15e-05	0.000359	CcSEcCtD
Pentamidine—Abdominal pain—Methotrexate—urinary bladder cancer	4.13e-05	0.000358	CcSEcCtD
Pentamidine—Body temperature increased—Methotrexate—urinary bladder cancer	4.13e-05	0.000358	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	4.12e-05	0.000357	CcSEcCtD
Pentamidine—Insomnia—Doxorubicin—urinary bladder cancer	4.09e-05	0.000354	CcSEcCtD
Pentamidine—Paraesthesia—Doxorubicin—urinary bladder cancer	4.06e-05	0.000352	CcSEcCtD
Pentamidine—Dyspnoea—Doxorubicin—urinary bladder cancer	4.03e-05	0.000349	CcSEcCtD
Pentamidine—Feeling abnormal—Epirubicin—urinary bladder cancer	4.02e-05	0.000349	CcSEcCtD
Pentamidine—Somnolence—Doxorubicin—urinary bladder cancer	4.02e-05	0.000348	CcSEcCtD
Pentamidine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	3.99e-05	0.000346	CcSEcCtD
Pentamidine—Dyspepsia—Doxorubicin—urinary bladder cancer	3.98e-05	0.000345	CcSEcCtD
Pentamidine—Decreased appetite—Doxorubicin—urinary bladder cancer	3.93e-05	0.000341	CcSEcCtD
Pentamidine—Fatigue—Doxorubicin—urinary bladder cancer	3.9e-05	0.000338	CcSEcCtD
Pentamidine—Urticaria—Epirubicin—urinary bladder cancer	3.88e-05	0.000336	CcSEcCtD
Pentamidine—Pain—Doxorubicin—urinary bladder cancer	3.86e-05	0.000335	CcSEcCtD
Pentamidine—Constipation—Doxorubicin—urinary bladder cancer	3.86e-05	0.000335	CcSEcCtD
Pentamidine—Abdominal pain—Epirubicin—urinary bladder cancer	3.86e-05	0.000335	CcSEcCtD
Pentamidine—Body temperature increased—Epirubicin—urinary bladder cancer	3.86e-05	0.000335	CcSEcCtD
Pentamidine—Hypersensitivity—Methotrexate—urinary bladder cancer	3.85e-05	0.000333	CcSEcCtD
Pentamidine—Asthenia—Methotrexate—urinary bladder cancer	3.74e-05	0.000325	CcSEcCtD
Pentamidine—Feeling abnormal—Doxorubicin—urinary bladder cancer	3.72e-05	0.000323	CcSEcCtD
Pentamidine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	3.7e-05	0.00032	CcSEcCtD
Pentamidine—Pruritus—Methotrexate—urinary bladder cancer	3.69e-05	0.00032	CcSEcCtD
Pentamidine—Hypersensitivity—Epirubicin—urinary bladder cancer	3.6e-05	0.000312	CcSEcCtD
Pentamidine—Urticaria—Doxorubicin—urinary bladder cancer	3.59e-05	0.000311	CcSEcCtD
Pentamidine—Abdominal pain—Doxorubicin—urinary bladder cancer	3.57e-05	0.00031	CcSEcCtD
Pentamidine—Body temperature increased—Doxorubicin—urinary bladder cancer	3.57e-05	0.00031	CcSEcCtD
Pentamidine—Diarrhoea—Methotrexate—urinary bladder cancer	3.57e-05	0.00031	CcSEcCtD
Pentamidine—Asthenia—Epirubicin—urinary bladder cancer	3.5e-05	0.000304	CcSEcCtD
Pentamidine—Pruritus—Epirubicin—urinary bladder cancer	3.46e-05	0.0003	CcSEcCtD
Pentamidine—Dizziness—Methotrexate—urinary bladder cancer	3.45e-05	0.000299	CcSEcCtD
Pentamidine—Diarrhoea—Epirubicin—urinary bladder cancer	3.34e-05	0.00029	CcSEcCtD
Pentamidine—Hypersensitivity—Doxorubicin—urinary bladder cancer	3.33e-05	0.000289	CcSEcCtD
Pentamidine—Vomiting—Methotrexate—urinary bladder cancer	3.32e-05	0.000288	CcSEcCtD
Pentamidine—Rash—Methotrexate—urinary bladder cancer	3.29e-05	0.000285	CcSEcCtD
Pentamidine—Dermatitis—Methotrexate—urinary bladder cancer	3.29e-05	0.000285	CcSEcCtD
Pentamidine—Headache—Methotrexate—urinary bladder cancer	3.27e-05	0.000283	CcSEcCtD
Pentamidine—Asthenia—Doxorubicin—urinary bladder cancer	3.24e-05	0.000281	CcSEcCtD
Pentamidine—Dizziness—Epirubicin—urinary bladder cancer	3.23e-05	0.00028	CcSEcCtD
Pentamidine—Pruritus—Doxorubicin—urinary bladder cancer	3.2e-05	0.000277	CcSEcCtD
Pentamidine—Vomiting—Epirubicin—urinary bladder cancer	3.11e-05	0.000269	CcSEcCtD
Pentamidine—Nausea—Methotrexate—urinary bladder cancer	3.1e-05	0.000269	CcSEcCtD
Pentamidine—Diarrhoea—Doxorubicin—urinary bladder cancer	3.09e-05	0.000268	CcSEcCtD
Pentamidine—Rash—Epirubicin—urinary bladder cancer	3.08e-05	0.000267	CcSEcCtD
Pentamidine—Dermatitis—Epirubicin—urinary bladder cancer	3.08e-05	0.000267	CcSEcCtD
Pentamidine—Headache—Epirubicin—urinary bladder cancer	3.06e-05	0.000265	CcSEcCtD
Pentamidine—Dizziness—Doxorubicin—urinary bladder cancer	2.99e-05	0.000259	CcSEcCtD
Pentamidine—Nausea—Epirubicin—urinary bladder cancer	2.9e-05	0.000252	CcSEcCtD
Pentamidine—Vomiting—Doxorubicin—urinary bladder cancer	2.87e-05	0.000249	CcSEcCtD
Pentamidine—Rash—Doxorubicin—urinary bladder cancer	2.85e-05	0.000247	CcSEcCtD
Pentamidine—Dermatitis—Doxorubicin—urinary bladder cancer	2.85e-05	0.000247	CcSEcCtD
Pentamidine—Headache—Doxorubicin—urinary bladder cancer	2.83e-05	0.000245	CcSEcCtD
Pentamidine—Nausea—Doxorubicin—urinary bladder cancer	2.68e-05	0.000233	CcSEcCtD
Pentamidine—CYP4A11—Metabolism—NQO1—urinary bladder cancer	2.09e-05	0.000317	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—HRAS—urinary bladder cancer	2.05e-05	0.000312	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	2.04e-05	0.00031	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.02e-05	0.000307	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	2.02e-05	0.000307	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	1.99e-05	0.000302	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	1.97e-05	0.000299	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	1.96e-05	0.000298	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—FGFR3—urinary bladder cancer	1.95e-05	0.000296	CbGpPWpGaD
Pentamidine—S100B—Immune System—IL2—urinary bladder cancer	1.95e-05	0.000295	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP4B1—urinary bladder cancer	1.93e-05	0.000293	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	1.93e-05	0.000293	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	1.92e-05	0.000291	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	1.92e-05	0.000291	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—ESR1—urinary bladder cancer	1.89e-05	0.000287	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.89e-05	0.000287	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	1.88e-05	0.000286	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	1.86e-05	0.000283	CbGpPWpGaD
Pentamidine—S100B—Immune System—CDKN1A—urinary bladder cancer	1.83e-05	0.000279	CbGpPWpGaD
Pentamidine—S100B—Immune System—PTEN—urinary bladder cancer	1.83e-05	0.000278	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	1.83e-05	0.000277	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—SLC19A1—urinary bladder cancer	1.82e-05	0.000277	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	1.8e-05	0.000274	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PRSS3—urinary bladder cancer	1.78e-05	0.00027	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	1.77e-05	0.000269	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.77e-05	0.000268	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	1.77e-05	0.000268	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	1.77e-05	0.000268	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	1.76e-05	0.000267	CbGpPWpGaD
Pentamidine—S100B—Immune System—EP300—urinary bladder cancer	1.75e-05	0.000265	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—GSTP1—urinary bladder cancer	1.74e-05	0.000264	CbGpPWpGaD
Pentamidine—S100B—Immune System—SRC—urinary bladder cancer	1.7e-05	0.000258	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.68e-05	0.000256	CbGpPWpGaD
Pentamidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	1.68e-05	0.000255	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	1.67e-05	0.000254	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CREBBP—urinary bladder cancer	1.66e-05	0.000252	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IGF1—urinary bladder cancer	1.64e-05	0.000249	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	1.63e-05	0.000247	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—TYMS—urinary bladder cancer	1.62e-05	0.000246	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	1.61e-05	0.000245	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—GSTM1—urinary bladder cancer	1.6e-05	0.000243	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—NCOR1—urinary bladder cancer	1.6e-05	0.000243	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	1.58e-05	0.00024	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	1.58e-05	0.00024	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—GPX1—urinary bladder cancer	1.53e-05	0.000233	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—TYMP—urinary bladder cancer	1.5e-05	0.000228	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—ERCC2—urinary bladder cancer	1.5e-05	0.000228	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—RHOA—urinary bladder cancer	1.5e-05	0.000228	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	1.5e-05	0.000227	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	1.5e-05	0.000227	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	1.49e-05	0.000227	CbGpPWpGaD
Pentamidine—S100B—Immune System—EGFR—urinary bladder cancer	1.49e-05	0.000226	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.47e-05	0.000223	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	1.45e-05	0.000221	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	1.45e-05	0.000221	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.43e-05	0.000216	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—TYMP—urinary bladder cancer	1.42e-05	0.000216	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—MTHFR—urinary bladder cancer	1.41e-05	0.000215	CbGpPWpGaD
Pentamidine—S100B—Immune System—KRAS—urinary bladder cancer	1.41e-05	0.000213	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—ERBB2—urinary bladder cancer	1.39e-05	0.000211	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	1.37e-05	0.000208	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	1.37e-05	0.000208	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.36e-05	0.000207	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—NAT2—urinary bladder cancer	1.36e-05	0.000207	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	1.34e-05	0.000203	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CXCL8—urinary bladder cancer	1.32e-05	0.0002	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.31e-05	0.000198	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—TYMP—urinary bladder cancer	1.3e-05	0.000198	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—NAT2—urinary bladder cancer	1.29e-05	0.000195	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL2—urinary bladder cancer	1.26e-05	0.000191	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.25e-05	0.00019	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	1.23e-05	0.000187	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CCND1—urinary bladder cancer	1.23e-05	0.000186	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.22e-05	0.000185	CbGpPWpGaD
Pentamidine—S100B—Immune System—HRAS—urinary bladder cancer	1.19e-05	0.000181	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MMP9—urinary bladder cancer	1.19e-05	0.000181	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CDKN1A—urinary bladder cancer	1.19e-05	0.00018	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PTEN—urinary bladder cancer	1.18e-05	0.00018	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NAT2—urinary bladder cancer	1.18e-05	0.000179	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—RRM2—urinary bladder cancer	1.17e-05	0.000178	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.17e-05	0.000177	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	1.16e-05	0.000177	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	1.16e-05	0.000177	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.15e-05	0.000175	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.15e-05	0.000175	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PPARG—urinary bladder cancer	1.15e-05	0.000174	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	1.13e-05	0.000172	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EP300—urinary bladder cancer	1.13e-05	0.000171	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.12e-05	0.00017	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—RRM2—urinary bladder cancer	1.11e-05	0.000168	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CREBBP—urinary bladder cancer	1.1e-05	0.000167	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—SRC—urinary bladder cancer	1.1e-05	0.000167	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ENO2—urinary bladder cancer	1.09e-05	0.000165	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	1.09e-05	0.000165	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	1.07e-05	0.000162	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.06e-05	0.00016	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	1.05e-05	0.00016	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	1.05e-05	0.00016	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	1.03e-05	0.000156	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ENO2—urinary bladder cancer	1.03e-05	0.000156	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.02e-05	0.000155	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.02e-05	0.000154	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	9.96e-06	0.000151	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MYC—urinary bladder cancer	9.84e-06	0.000149	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.81e-06	0.000149	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	9.67e-06	0.000147	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EGFR—urinary bladder cancer	9.62e-06	0.000146	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	9.5e-06	0.000144	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	9.42e-06	0.000143	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	9.42e-06	0.000143	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.36e-06	0.000142	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	9.13e-06	0.000139	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—KRAS—urinary bladder cancer	9.09e-06	0.000138	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	9.09e-06	0.000138	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	9.08e-06	0.000138	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	9.06e-06	0.000138	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTGS2—urinary bladder cancer	9.02e-06	0.000137	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.99e-06	0.000137	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	8.97e-06	0.000136	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	8.76e-06	0.000133	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	8.75e-06	0.000133	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.7e-06	0.000132	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	8.41e-06	0.000128	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	8.41e-06	0.000128	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.36e-06	0.000127	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	8.35e-06	0.000127	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—NQO1—urinary bladder cancer	8.28e-06	0.000126	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	8.19e-06	0.000124	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	8.15e-06	0.000124	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—urinary bladder cancer	8.08e-06	0.000123	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.03e-06	0.000122	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.03e-06	0.000122	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTEN—urinary bladder cancer	7.86e-06	0.000119	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	7.73e-06	0.000117	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	7.73e-06	0.000117	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HRAS—urinary bladder cancer	7.72e-06	0.000117	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	7.59e-06	0.000115	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	7.5e-06	0.000114	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—EP300—urinary bladder cancer	7.5e-06	0.000114	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.37e-06	0.000112	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	7.31e-06	0.000111	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	7.07e-06	0.000107	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.01e-06	0.000106	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	6.99e-06	0.000106	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	6.91e-06	0.000105	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	6.8e-06	0.000103	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	6.78e-06	0.000103	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	6.72e-06	0.000102	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	6.72e-06	0.000102	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.68e-06	0.000101	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.57e-06	9.98e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	6.55e-06	9.95e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	6.55e-06	9.95e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.51e-06	9.89e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	6.43e-06	9.77e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.42e-06	9.76e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—TYMS—urinary bladder cancer	6.42e-06	9.75e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	6.35e-06	9.65e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	6.35e-06	9.64e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	6.35e-06	9.64e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	6.33e-06	9.62e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	6.32e-06	9.6e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	6.32e-06	9.59e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.26e-06	9.5e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	6.23e-06	9.47e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.13e-06	9.3e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GPX1—urinary bladder cancer	6.08e-06	9.23e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	5.97e-06	9.06e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	5.94e-06	9.02e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	5.89e-06	8.94e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	5.82e-06	8.84e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	5.82e-06	8.84e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.73e-06	8.71e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	5.65e-06	8.58e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	5.61e-06	8.52e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	5.57e-06	8.46e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	5.47e-06	8.31e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.47e-06	8.3e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	5.46e-06	8.29e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	5.28e-06	8.02e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	5.25e-06	7.98e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	5.2e-06	7.89e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	5.19e-06	7.89e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	5.19e-06	7.89e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	5.14e-06	7.81e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.12e-06	7.78e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	5.06e-06	7.68e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	5.06e-06	7.68e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	4.97e-06	7.55e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	4.9e-06	7.45e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	4.88e-06	7.42e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	4.83e-06	7.34e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	4.81e-06	7.31e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	4.78e-06	7.25e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	4.78e-06	7.25e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	4.62e-06	7.02e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	4.59e-06	6.97e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	4.57e-06	6.95e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPARG—urinary bladder cancer	4.55e-06	6.91e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	4.49e-06	6.82e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.47e-06	6.78e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	4.4e-06	6.69e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	4.37e-06	6.64e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.26e-06	6.47e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	4.22e-06	6.41e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	4.17e-06	6.33e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	4.09e-06	6.22e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	4.07e-06	6.19e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	4.05e-06	6.15e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	4.05e-06	6.15e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	4.01e-06	6.08e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	3.88e-06	5.89e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	3.8e-06	5.78e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	3.79e-06	5.75e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	3.72e-06	5.65e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	3.58e-06	5.43e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	3.58e-06	5.43e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	3.58e-06	5.43e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	3.42e-06	5.2e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	3.4e-06	5.16e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	3.3e-06	5.02e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	3.29e-06	4.99e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	3.28e-06	4.98e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	3.16e-06	4.8e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—EP300—urinary bladder cancer	3.15e-06	4.78e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	3.12e-06	4.74e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	3.12e-06	4.74e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTEN—urinary bladder cancer	3.12e-06	4.74e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.99e-06	4.54e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—EP300—urinary bladder cancer	2.98e-06	4.52e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2.94e-06	4.46e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	2.93e-06	4.45e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	2.9e-06	4.4e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	2.86e-06	4.34e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	2.79e-06	4.23e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.76e-06	4.19e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—EP300—urinary bladder cancer	2.73e-06	4.14e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	2.69e-06	4.09e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	2.55e-06	3.88e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—EP300—urinary bladder cancer	2.44e-06	3.7e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	2.35e-06	3.57e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	2.28e-06	3.46e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—EP300—urinary bladder cancer	2.24e-06	3.4e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	2.24e-06	3.4e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	2.15e-06	3.27e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.99e-06	3.02e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.9e-06	2.88e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.76e-06	2.67e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.54e-06	2.33e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.46e-06	2.22e-05	CbGpPWpGaD
